| About the author: |
G. M. Ismayilov |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
Two samples of 250 patients with diabetic retinopathy were retrospectively formed before the introduction of compulsory health insurance (2018–2019) and after it (2021–2022). For all patients, standard information was collected, which included data on gender, age, type and duration, as well as treatment options for diabetes mellitus, the stage of diabetic retinopathy (non-proliferative, preproliferative, proliferative), form (exudative, edematous, ischemic) and type (focal, diffuse, cystic and cystic with the presence of vitreoretinal fractions) maculopathy, as well as comorbid eye pathologies (secondary glaucoma, cataracts, age-related macular degeneration, vitreous diseases and others). A comparison of the treatment results in the clinic before and after the introduction of compulsory health insurance shows that the difference between them is also statistically significant (p<0.05). Eliminating financial restrictions for the treatment of diabetic retinopathy through the introduction of compulsory health insurance leads to a change in the clinical profile of hospitalized patients and increase in the adequacy of treatment using high-tech medical care. |
| Tags |
diabetic retinopathy,compulsory health insurance,maculopathy,laser coagulation |
| Bibliography |
- Aliyeva NI, Kasimov EM. Otsenka effektivnosti lecheniya diabeticheskogo gemoftalma. Oftalmologiya.2013; 3 (13): 81–25 [in Russian]
- Vorobyeva IV. Otdalennyye rezultaty lecheniya patsiyentov s neproliferativnoy diabeticheskoy retinopatiyey angioprotektorom. Oftalmologiya. 2017; 14 (1): 67–72. [in Russian]
- Zakharov VD, Yakushev PV, Nosirova AO, Gorodetskaya YuB. Otsenka. effektivnosti lecheniya. Meditsinskiy vestnik Bashkortostana. 2018; 1 (73): 33–36 [in Russian]
- Tereshenko AV, Trifanenkova ChG, Alkhimova DV. Vysokotekhnologichnaya meditsinskaya pomoshch v oftalmologii: organizatsionnyye i tekhnicheskiye aspekty. Zhurnal Meditsina. 2018; 1: 72–86 [in Russian]
- Tsipyashchuk AF, Kamenskaya TG, Reshetnikova LB, Polozova NA. Vysokotekhnologichnaya oftalmologicheskaya pomoshch v klinike glaznykh bolezney Saratovskogo Gosudarstvennogo Meditsinskogo Universiteta. Saratovskiy nauchno-meditsinskiy zhurnal. 2017; 13(2): 329–334 [in Russian]
- Agroiya P, Alrawahi AH, Pambinezhuth F, Al Busaidi NB. Diabetic retinopathy among Omanis: Prevalence and clinical profile. Oman J Ophthalmol. 2020 May 28;13(2):76–83. doi: 10.4103/ojo.OJO_225_2019.
- Chetan TL, Itagi AS, Kumar A, Neeralagi S. Clinical Profile of Diabetic Nephropathy and Diabetic Retinopathy in a Tertiary Care Hospital. Asian J. Med. Res. 2022;11(2):7–12. doi: dx.doi.org/10.47009/ajmr.2022.11.2.2
- Das AV, Prashanthi GS, Das T, Narayanan R, Rani PK. Clinical profile and magnitude of diabetic retinopathy: An electronic medical record-driven big data analytics from an eye care network in India. Indian J Ophthalmol. 2021 Nov;69(11):3110–3117. doi: 10.4103/ijo.IJO_1490_21.
- Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021 Aug;12(8):1322–1325. doi: 10.1111/jdi.13480.
- Mansour SE, Browning DJ, Wong K, Flynn HW Jr, Bhavsar AR. The Evolving Treatment of Diabetic Retinopathy. Clin Ophthalmol. 2020 Mar 4; 14:653–678. doi: 10.2147/OPTH.S236637.
- Muqit MMK, Kourgialis N, Jackson-deGraffenried M, Talukder Z, Khetran ER, Rahman A, et al. Trends in Diabetic Retinopathy, Visual Acuity, and Treatment Outcomes for Patients Living with Diabetes in a Fundus Photograph-Based Diabetic Retinopathy Screening Program in Bangladesh. JAMA Netw Open. 2019 Nov 1;2(11):1916285. doi: 10.1001/jamanetworkopen.2019.16285.
- Pera-Vasylchenko AV, Ryadnova VV, Voskresenska LK, Bezkorovayna IM, Bezega НМ. Pethoorphological changes of the optical nerve intracranial part in diabetes mellitus. World of Medicine and Biology. 2021; 1(75): 201–205. doi:10.26724/2079-8334-2021-1-75-201-205
- Sapkota R, Chen Z, Zheng D, Pardhan S. The profile of sight-threatening diabetic retinopathy in patients attending a specialist eye clinic in Hangzhou, China. BMJ Open Ophthalmol. 2019 Apr 11;4(1):000236. doi: 10.1136/bmjophth-2018-000236.
- Saw M, Wong VW, Ho IV, Liew G. New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy. Eye (Lond). 2019 Dec; 33(12):1842–1851. doi: 10.1038/s41433-019-0494-z.
|
| Publication of the article |
«World of Medicine and Biology» №4(86), 2023 year, 057-060 pages, index UDK 617.735-02:616.379-008.64 |
| DOI |
10.26724/2079-8334-2023-4-86-57-60 |
